Carl Dambkowski - Mar 5, 2025 Form 4 Insider Report for Apogee Therapeutics, Inc. (APGE)

Role
Chief Medical Officer
Signature
/s/ Matthew Batters, as attorney-in-fact for Carl Dambkowski
Stock symbol
APGE
Transactions as of
Mar 5, 2025
Transactions value $
-$48,463
Form type
4
Date filed
3/7/2025, 08:02 PM
Previous filing
Feb 7, 2025
Next filing
Apr 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APGE Common Stock Sale -$48.5K -1.59K -0.63% $30.48 251K Mar 5, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2024.